Medication adherence, depression and disease activity among patients with systemic lupus erythematosus - PubMed (original) (raw)
. 2018 Feb;27(2):327-332.
doi: 10.1177/0961203317725585. Epub 2017 Aug 21.
Affiliations
- PMID: 28825347
- DOI: 10.1177/0961203317725585
Medication adherence, depression and disease activity among patients with systemic lupus erythematosus
N Alsowaida et al. Lupus. 2018 Feb.
Abstract
Introduction Medication non-adherence is an important cause of treatment failure among patients with systemic lupus erythematosus (SLE). Depression is a common neuropsychiatric disorder associated with SLE. The aims of this study are to assess the prevalence of both medication non-adherence and depressed mood among Saudi patients with SLE by using validated tools and to explore the impact of both depressive symptoms and disease activity on medication non-adherence. Methods A cross-sectional study was conducted in outpatients with SLE. Medication non-adherence was assessed by using the Morisky Medication Adherence Scale, and the severity of depressed mood was evaluated with the Beck's Depression Inventory. Disease activity was measured using the SLE Disease Activity Index (SLEDAI). Multiple logistic regression models were used to identify the multivariate predictors of medication non-adherence. Results Out of 140 patients, 134 (95.7%) were females with a mean (±SD) age of 35.6 (±11.3) years and a disease duration of 8.8 (±6.7) years. Medication non-adherence and depressed mood were detected in 62.1% and 35% of the patients, respectively. A moderate or severe depressed mood was significantly associated with medication non-adherence ( p = 0.04). There was a significant correlation between disease activity and the severity of depressed mood ( r = 0.31, p = 0.003). Disease activity did not correlate with medication non-adherence. Logistic regression demonstrated that moderate-to-severe depressed mood increased the probability of medication non-adherence (OR 2.62; 1.02-6.71). Conclusion Medication non-adherence and depressive symptoms are highly prevalent among Saudi SLE patients. Routine screening could facilitate the early detection and management of depression and medication adherence.
Keywords: Systemic lupus erythematosus; adherence; depression.
Similar articles
- Medication Adherence in Chinese Patients With Systemic Lupus Erythematosus.
Du X, Chen H, Zhuang Y, Zhao Q, Shen B. Du X, et al. J Clin Rheumatol. 2020 Apr;26(3):94-98. doi: 10.1097/RHU.0000000000000952. J Clin Rheumatol. 2020. PMID: 30601165 - Active disease is independently associated with more severe anxiety rather than depressive symptoms in patients with systemic lupus erythematosus.
Tay SH, Cheung PP, Mak A. Tay SH, et al. Lupus. 2015 Nov;24(13):1392-9. doi: 10.1177/0961203315591026. Epub 2015 Jun 17. Lupus. 2015. PMID: 26085594 - Medication adherence is influenced by resilience in patients with systemic lupus erythematosus.
Mendoza-Pinto C, García-Carrasco M, Campos-Rivera S, Munguía-Realpozo P, Etchegaray-Morales I, Ayón-Aguilar J, Alonso-García NE, Méndez-Martínez S. Mendoza-Pinto C, et al. Lupus. 2021 Jun;30(7):1051-1057. doi: 10.1177/09612033211004722. Epub 2021 Apr 1. Lupus. 2021. PMID: 33794703 - DEPRESSION--A FELLOW TRAVELER WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
Cojocaru DC, Costin M, Bădeanu LE, Negru RD, Aursulesei V. Cojocaru DC, et al. Rev Med Chir Soc Med Nat Iasi. 2015 Oct-Dec;119(4):974-81. Rev Med Chir Soc Med Nat Iasi. 2015. PMID: 26793837 Review. - Assessment of the Hospital Anxiety and Depression Scale (HADS) performance for the diagnosis of anxiety in patients with systemic lupus erythematosus.
de Almeida Macêdo E, Appenzeller S, Lavras Costallat LT. de Almeida Macêdo E, et al. Rheumatol Int. 2017 Dec;37(12):1999-2004. doi: 10.1007/s00296-017-3819-x. Epub 2017 Sep 22. Rheumatol Int. 2017. PMID: 28940018 Review.
Cited by
- Development of a nomogram prediction model for depression in patients with systemic lupus erythematosus.
Chen H, Cui H, Geng Y, Jin T, Shi S, Li Y, Chen X, Shen B. Chen H, et al. Front Psychol. 2022 Sep 14;13:951431. doi: 10.3389/fpsyg.2022.951431. eCollection 2022. Front Psychol. 2022. PMID: 36186364 Free PMC article. - Transition and transfer of the patient with paediatric-onset lupus: a practical approach for paediatric and adult rheumatology practices.
Sadun RE, Schanberg LE. Sadun RE, et al. Lupus Sci Med. 2018 Aug 13;5(1):e000282. doi: 10.1136/lupus-2018-000282. eCollection 2018. Lupus Sci Med. 2018. PMID: 30167316 Free PMC article. - Updated advances of linking psychosocial factors and sex hormones with systemic lupus erythematosus susceptibility and development.
Pan Q, Chen X, Liao S, Chen X, Zhao C, Xu YZ, Liu HF. Pan Q, et al. PeerJ. 2019 Jun 25;7:e7179. doi: 10.7717/peerj.7179. eCollection 2019. PeerJ. 2019. PMID: 31275761 Free PMC article. - Mendelian randomization study on the causal effects of systemic lupus erythematosus on major depressive disorder.
Li W, Kan H, Zhang W, Zhong Y, Liao W, Huang G, Wu P. Li W, et al. J Hum Genet. 2023 Jan;68(1):11-16. doi: 10.1038/s10038-022-01080-7. Epub 2022 Nov 1. J Hum Genet. 2023. PMID: 36316471 Free PMC article. - Anxiety and Mood Disorders in Systemic Lupus Erythematosus: Current Insights and Future Directions.
Tisseverasinghe A, Peschken C, Hitchon C. Tisseverasinghe A, et al. Curr Rheumatol Rep. 2018 Nov 12;20(12):85. doi: 10.1007/s11926-018-0797-2. Curr Rheumatol Rep. 2018. PMID: 30417270 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical